Noticias científicas

2021 European Heart RhythmAssociation Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation

Fuente: EP Europace
Fecha publicación: 25 de abril de 2021

Jan Steffel, Ronan Collins, Matthias Antz, Pieter Cornu, Lien Desteghe, Karl Georg Haeusler, Jonas Oldgren, Holger Reinecke, Vanessa Roldan-Schilling, Nigel Rowell, Peter Sinnaeve, Thomas Vanassche, Tatjana Potpara, A. John Camm, and Hein Heidbüchel.

Artículo íntegro en EP Europace  |   Artículo en formato PDF

Table of Content

• Abbreviations
• Introduction
• NOACeligibility and dosing
• Practical considerations for initiation and follow-up
• Pharmacokinetics and drug–drug interactions ofNOACs
• NOACs in patients with chronic kidney disease or advanced liver disease
• NOAC plasma level measurements: Technical approach, indications, pitfalls
• Management of bleeding under NOAC therapy
• Patients requiring an urgent surgical intervention
• Patients undergoing a planned invasive procedure, surgery,or ablation
• Patients with atrial fibrillation and coronary artery disease
• Cardioversion in aNOAC-treated patient
• AF patients presenting with acute stroke while onNOACs
• NOACs in advanced age and frailty
• NOACs in high- and lowbodyweights
• NOACs inother special populations
• NOACs in patients with atrial fibrillation and malignancy
• Optimizing dose adjustments of vitamin-K antagonist